Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
===============================================================================================================================================

* Kevin Conlon
* Dionysios C Watson
* Thomas A Waldmann
* Antonio Valentin
* Cristina Bergamaschi
* Barbara K Felber
* Cody J Peer
* William D Figg
* E Lake Potter
* Mario Roederer
* Douglas G McNeel
* John A Thompson
* Sumati Gupta
* Rom Leidner
* Andrea Wang-Gillam
* Nehal S Parikh
* Debby Long
* Sema Kurtulus
* Lang Ho Lee
* Niladri Roy Chowdhury
* Florent Bender
* George N Pavlakis